Olaf‐Georg Issinger

5.8k total citations
142 papers, 4.9k citations indexed

About

Olaf‐Georg Issinger is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Olaf‐Georg Issinger has authored 142 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 33 papers in Oncology and 31 papers in Materials Chemistry. Recurrent topics in Olaf‐Georg Issinger's work include Protein Kinase Regulation and GTPase Signaling (50 papers), Enzyme Structure and Function (30 papers) and Cancer-related Molecular Pathways (26 papers). Olaf‐Georg Issinger is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (50 papers), Enzyme Structure and Function (30 papers) and Cancer-related Molecular Pathways (26 papers). Olaf‐Georg Issinger collaborates with scholars based in Denmark, Germany and United States. Olaf‐Georg Issinger's co-authors include Bárbara Guerra, Brigitte Boldyreff, Karsten Niefind, Jennifer Raaf, Lorenzo A. Pinna, Birgitte Brinkmann Olsen, Christina W. Yde, Nikodem Grankowski, Gerhard Seitz and Oriano Marin and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Journal of Molecular Biology.

In The Last Decade

Olaf‐Georg Issinger

142 papers receiving 4.8k citations

Peers

Countries citing papers authored by Olaf‐Georg Issinger

Since Specialization

Citations

This map shows the geographic impact of Olaf‐Georg Issinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf‐Georg Issinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf‐Georg Issinger more than expected).

Fields of papers citing papers by Olaf‐Georg Issinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf‐Georg Issinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf‐Georg Issinger. The network helps show where Olaf‐Georg Issinger may publish in the future.

Co-authorship network of co-authors of Olaf‐Georg Issinger

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf‐Georg Issinger. A scholar is included among the top collaborators of Olaf‐Georg Issinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf‐Georg Issinger. Olaf‐Georg Issinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling 2021 ·Biomedicine & Pharmacotherapy ·Olaf‐Georg Issinger, Bárbara Guerra	29
2	Delivery of proteins encapsulated in chitosan-tripolyphosphate nanoparticles to human skin melanoma cells 2018 ·Colloids and Surfaces B Biointerfaces ·Mai Bay Stie, (unknown), Olaf‐Georg Issinger, (unknown), Bárbara Guerra, Lars Folke Olsen	25
3	Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells 2014 ·Cancer Letters ·Bárbara Guerra, (unknown), (unknown), (unknown), Brigitte Boldyreff, Yoshihiko Miyata, Niels Marcussen, Karsten Niefind, Olaf‐Georg Issinger	27
4	Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction 2014 ·Analytical Biochemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Stefan Herzig, Olaf‐Georg Issinger, Volkhard Helms, Claudia Götz, Ines Neundorf, Karsten Niefind, Markus Pietsch	19
5	2-Triazenoazaindoles: A novel class of triazenes inducing transcriptional down-regulation of EGFR and HER-2 in human pancreatic cancer cells 2011 ·International Journal of Oncology ·(unknown), Alessia Salvador, Patrizia Diana, Girolamo Cirrincione, Daniela Vedaldi, David W. Litchfield, Olaf‐Georg Issinger, Bárbara Guerra	3
6	The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules 2008 ·Chemistry & Biology ·Jennifer Raaf, Elena Brunstein, Olaf‐Georg Issinger, Karsten Niefind	84
7	The interaction of CK2α and CK2β, the subunits of protein kinase CK2, requires CK2β in a preformed conformation and is enthalpically driven 2008 ·Protein Science ·Jennifer Raaf, Elena Brunstein, Olaf‐Georg Issinger, Karsten Niefind	43
8	Protein Kinase CK2 in Human Diseases 2008 ·Current Medicinal Chemistry ·Bárbara Guerra, Olaf‐Georg Issinger	215
9	Pyrazole carboxamides and carboxylic acids as protein kinase inhibitors in aberrant eukaryotic signal transduction: induction of growth arrest in MCF-7 cancer cells 2007 ·Organic & Biomolecular Chemistry ·Tobias Persson, Christina W. Yde, (unknown), Tine L. Rasmussen, Bárbara Guerra, Olaf‐Georg Issinger, John Nielsen	13
10	Epitope Analysis of the MAb 1AD9 Antibody Detection Site in Human Protein Kinase CK2 α -Subunit 2003 ·PubMed ·Wolfgang Nastainczyk, Olaf‐Georg Issinger, Bárbara Guerra	11
11	Disruption of the Regulatory β Subunit of Protein Kinase CK2 in Mice Leads to a Cell-Autonomous Defect and Early Embryonic Lethality 2003 ·Molecular and Cellular Biology ·Thierry Buchou, Muriel Vernet, (unknown), (unknown), Hervé Pointu, Birgitte Brinkmann Olsen, Claude Cochet, Olaf‐Georg Issinger, Brigitte Boldyreff	210
12	Protein kinase CK2 phosphorylates the Fas‐associated factor FAF1 in vivo and influences its transport into the nucleus 2003 ·FEBS Letters ·Birgitte Brinkmann Olsen, (unknown), Peter Højrup, Olaf‐Georg Issinger, Brigitte Boldyreff	17
13	The subcellular distribution of the human ribosomal “stalk” components: P1, P2 and P0 proteins 2002 ·The International Journal of Biochemistry & Cell Biology ·Marek Tchórzewski, Dawid Krokowski, Wojciech Rzeski, Olaf‐Georg Issinger, Nikodem Grankowski	27
14	The C‐terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2α) against thermal aggregation 2001 ·European Journal of Biochemistry ·Nerea Roher, Francesc Miró‐Mur, Brigitte Boldyreff, Franc Llorens, Maria Plana, Olaf‐Georg Issinger, Emilio Itarte	16
15	Protein kinase CK2: evidence for a protein kinase CK2β subunit fraction, devoid of the catalytic CK2α subunit, in mouse brain and testicles 1999 ·FEBS Letters ·Bárbara Guerra, Stefan Siemer, Brigitte Boldyreff, Olaf‐Georg Issinger	108
16	p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment 1998 ·FEBS Letters ·Bárbara Guerra, Olaf‐Georg Issinger	18
17	The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation 1997 ·Oncogene ·Bárbara Guerra, Claudia Götz, P. Wagner, Mathias Montenarh, Olaf‐Georg Issinger	59
18	Discrimination between Acid and Alkali-Labile Phosphorylated Residues on Immobilon: Phosphorylation Studies of Nucleoside Diphosphate Kinase 1996 ·Analytical Biochemistry ·Ricardo M. Biondi, Katherina Walz, Olaf‐Georg Issinger, Matthias Engel, Susana Passeron	14
19	Isolation and Characterization of a Monoclonal Anti CK-2 α Subunit Antibody of the IgGl Subclass 1992 ·Hybridoma ·(unknown), Brigitte Boldyreff, Olaf‐Georg Issinger	11
20	Isolation and characterization of recombinant human casein kinase II subunits α and β from bacteria 1991 ·European Journal of Biochemistry ·Nikodem Grankowski, Brigitte Boldyreff, Olaf‐Georg Issinger	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact